Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice

Cancer Research

Volumn 69, Issue 3, 2009, Pages 863-872

  Kuznetsov, Sergey G ^a,c   Haines, Diana C ^b   Martin, Betty K ^a   Sharan, Shyam K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RAD51 PROTEIN; RAD51C PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CHROMOSOME 11; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE DELETION; GENE INTERACTION; GENE MUTATION; GENE TARGETING; HETEROZYGOSITY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEBACEOUS GLAND TUMOR; SEX DIFFERENCE;

ADENOCARCINOMA, SEBACEOUS; ALLELES; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; EMBRYONIC DEVELOPMENT; EMBRYONIC STEM CELLS; FEMALE; GENES, TUMOR SUPPRESSOR; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RAD51 RECOMBINASE; SEBACEOUS GLAND NEOPLASMS; SEX FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 59149088203     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3057     Document Type: Article

References (54)

1. Shrivastav M, De Haro LP, Nickoloff JA. Regulation of DNA double-strand break repair pathway choice. Cell Res 2008;18:134-47.
2. Bianco PR, Tracy RB, Kowalczykowski SC. DNA strand exchange proteins: a biochemical and physical comparison. Front Biosci 1998;3:D570-603.
3. Kawabata M, Kawabata T, Nishibori M. Role of recA/RAD51 family proteins in mammals. Acta Med Okayama 2005;59:1-9.
4. Masson JY, Tarsounas MC, Stasiak AZ, et al. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev 2001;15:3296-307.
5. Masson JY, Stasiak AZ, Stasiak A, Benson FE, West SC. Complex formation by the human RAD51C and XRCC3 recombination repair proteins. Proc Natl Acad Sci U S A 2001;98:8440-6.
6. Yonetani Y, Hochegger H, Sonoda E, et al. Differential and collaborative actions of Rad51 paralog proteins in cellular response to DNA damage. Nucleic Acids Res 2005;33:4544-52.
7. van Veelen LR, Essers J, van de Rakt MW, et al. Ionizing radiation-induced foci formation of mammalian Rad51 and Rad54 depends on the Rad51 paralogs, but not on Rad52. Mutat Res 2005;574:34-49.
8. Takata M, Sasaki MS, Tachiiri S, et al. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol Cell Biol 2001;21:2858-66.
9. Pittman DL, Cobb J, Schimenti KJ, et al. Meiotic prophase arrest with failure of chromosome synapsis in mice deficient for Dmc1, a germline-specific RecA homolog. Mol Cell 1998;1:697-705.
10. Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett 2005;219:125-35.
11. Bärlund M, Tirkkonen M, Forozan F, Tanner MM, Kallioniemi O, Kallioniemi A. Increased copy number at 17q22-24 by CGH in breast cancer is due to high-level amplification of two separate regions. Genes Chromosomes Cancer 1997;20:372-6.
12. Parssinen J, Kuukasjarvi T, Karhu R, Kallioniemi A. High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer. Br J Cancer 2007;96:1258-64.
13. Lim DS, Hasty P. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol Cell Biol 1996;16:7133-43.
14. Adam J, Deans B, Thacker J. A role for Xrcc2 in the early stages of mouse development. DNA Repair (Amst) 2007;6:224-34.
15. Deans B, Griffin CS, Maconochie M, Thacker J. Xrcc2 is required for genetic stability, embryonic neurogenesis and viability in mice. EMBO J 2000;19:6675-85.
16. Pittman DL, Schimenti JC. Midgestation lethality in mice deficient for the RecA-related gene, Rad51d/Rad51l3. Genesis 2000;26:167-73.
17. Shu Z, Smith S, Wang L, Rice MC, Kmiec EB. Disruption of muREC2/RAD51L1 in mice results in early embryonic lethality which can Be partially rescued in a p53(-/-) background. Mol Cell Biol 1999;19:8686-93.
18. Tsuzuki T, Fujii Y, Sakumi K, et al. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci U S A 1996;93:6236-40.
19. Kuznetsov S, Pellegrini M, Shuda K, et al. RAD51C deficiency in mice results in early prophase Iarres t in males and sister chromatid separation at metaphase II in females. J Cell Biol 2007;176:581-92.
20. Leasure CS, Chandler J, Gilbert DJ, et al. Sequence, chromosomal location and expression analysis of the murine homologue of human RAD51L2/RAD51C. Gene 2001;271:59-67.
21. Liu P, Jenkins NA, Copeland NG. A Highly Efficient Recombineering-Based Method for Generating Conditional Knockout Mutations. Genome Res 2003;1:476-84.
22. Tessarollo L. Manipulating mouse embryonic stem cells. Methods Mol Biol 2001;158:47-63.
23. Meyers EN, Lewandoski M, Martin GR. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 1998;18:136-41.
24. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992;356:215-21.
25. Hughes-Davies L, Huntsman D, Ruas M, et al. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 2003;115:523-35.
26. Parrinello S, Samper E, Krtolica A, et al. Oxygen sensitivity severely limits the replicative life span of murine fibroblasts. Nat Cell Biol 2003;5:741-7.
27. Kuznetsov SG, Liu P, Sharan SK. Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat Med 2008;14:875-81.
28. Lewandoski M, Meyers EN, Martin GR. Analysis of Fgf8 gene function in vertebrate development. Cold Spring Harb Symp Quant Biol 1997;62:159-68.
29. French CA, Tambini CE, Thacker J. Identification of functional domains in the RAD51L2 (RAD51C) protein and its requirement for gene conversion. J Biol Chem 2003;278:45445-50.
30. Brown EJ. Analysis of cell cycle progression and genomic integrity in early lethal knockouts. Methods Mol Biol 2004;280:201-12.
31. Kuperwasser C, Hurlbut GD, Kittrell FS, et al. Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome. Am J Pathol 2000;157:2151-9.
32. Hwang SJ, Lozano G, Amos CI, Strong LC. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet 2003;72:975-83.
33. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 2006;12:192-8.
34. Harvey M, McArthur MJ, Montgomery CA, et al. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet 1993;5:225-9.
35. Entius MM, Keller JJ, Drillenburg P, et al. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res 2000;6:1784-9.
36. Wojcik A, Stoilov L, Szumiel I, Legerski R, Obe G. Rad51C-deficient CL-V4B cells exhibit normal levels of mitomycin C-induced SCEs but reduced levels of UVC-induced SCEs. Biochem Biophys Res Commun 2005;326:805-10.
37. Tarsounas M, Munoz P, Claas A, et al. Telomere maintenance requires the RAD51D recombination/repair protein. Cell 2004;117:337-47.
38. Bleuyard JY, Gallego ME, Savigny F, White CI. Differing requirements for the Arabidopsis Rad51 paralogs in meiosis and DNA repair. Plant J 2005;41:533-45.
39. Liu Y, Masson JY, Shah R, O'Regan P, West SC. RAD51C is required for Holliday junction processing in mammalian cells. Science 2004;303:243-6.
40. Liu Y, Tarsounas M, O'Regan P, West SC. Role of RAD51C and XRCC3 in genetic recombination and DNA repair. J Biol Chem 2006;282:1973-9.
41. Liu X, Holstege H, van der Gulden H, et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc Natl Acad Sci U S A 2007;104:12111-6.
42. Frappart PO, Lee Y, Lamont J, McKinnon PJ. BRCA2 is required for neurogenesis and suppression of medulloblastoma. EMBO J 2007;26:2732-42.
43. Cheung AM, Elia A, Tsao MS, et al. Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice. Cancer Res 2004;64:1959-65.
44. Mao JH, Perez-Losada J, Wu D, et al. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 2004;432:775-9.
45. Ponzone R, Baum M. The BRCA paradox in breast and ovarian cancer. Eur J Cancer 1998;34:966-7.
46. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996;2:169-74.
47. Rustgi AK. The genetics of hereditary colon cancer. Genes Dev 2007;21:2525-38.
48. Mitsumori K, Elwell MR. Proliferative lesions in the male reproductive system of F344 rats and B6C3F1 mice: incidence and classification. Environ Health Perspect 1988;77:11-21.
49. Fong LY, Fidanza V, Zanesi N, et al. Muir-Torre-like syndrome in Fhit-deficient mice. Proc Natl Acad Sci U S A 2000;97:4742-7.
50. Niemann C, Owens DM, Schettina P, Watt FM. Dual role of inactivating Lef1 mutations in epidermis: tumor promotion and specification of tumor type. Cancer Res 2007;67:2916-21.
51. Zurcher M, Hintschich CR, Garner A, Bunce C, Collin JR. Sebaceous carcinoma of the eyelid: a clinicopathological study. Br J Ophthalmol 1998;82:1049-55.
52. Lai TF, Huilgol SC, Selva D, James CL. Eyelid sebaceous carcinoma masquerading as in situ squamous cell carcinoma. Dermatol Surg 2004;30:222-5.
53. Herschkowitz JI, Simin K, Weigman VJ, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007;8:R76.
54. Goldberg M, Rummelt C, Foja S, Holbach LM, Ballhausen WG. Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients. Hum Mutat 2006;27:155-62.